The middle area of the molecule (residues 5601438) is occupied by two domains: Cpn60_TCP1, with sequence similarity to molecular chaperonins, and a CHK homology region, with conserved Cys, His, and Lys residues uniquely displayed by the PIKfyve orthologs (7). formation or stability. Using the well established formation of aberrant cell vacuoles as a sensitive functional measure of localized PtdIns(3,5)P2reduction, we observed a mitigated vacuolar phenotype by kinase-deficient PIKfyveK1831Eif its ArPIKfyve-Sac3 binding region was deleted, suggesting reduced Sac3 access Oxtriphylline to, and turnover of PtdIns(3,5)P2. In contrast, PIKfyveK1831E, which displays intact ArPIKfyve-Sac3 binding, triggered a more severe vacuolar phenotype Mouse monoclonal to CD4.CD4 is a co-receptor involved in immune response (co-receptor activity in binding to MHC class II molecules) and HIV infection (CD4 is primary receptor for HIV-1 surface glycoprotein gp120). CD4 regulates T-cell activation, T/B-cell adhesion, T-cell diferentiation, T-cell selection and signal transduction if coexpressed with ArPIKfyveWT-Sac3WTbut minimal defects when coexpressed with ArPIKfyveWTand phosphatase-deficient Sac3D488A. These data indicate that Sac3 assembled in the PAS regulatory core complex is an active PtdIns(3,5)P2phosphatase. Based on these and other data, presented herein, we propose a model of Oxtriphylline domain interactions within the PAS core and their role in regulating the enzymatic activities. == Introduction == The seven phosphorylated derivatives of phosphatidylinositol (PtdIns),2called collectively PIs, are eukaryotic membrane-anchored signaling molecules that orchestrate diverse cellular processes, including intracellular membrane trafficking (16). PtdIns(3,5)P2, a low abundance PI comprising as little as 0.8% of total PIs in mammalian cells, mediates essential aspects of endocytic membrane homeostasis (7). Although mechanistic details remain to be elucidated, experimental evidence indicates that PtdIns(3,5)P2may coordinate fission and fusion events in the multivesicular endosomal system of mammalian cells (8,9). Consistent with these roles, perturbations in PtdIns(3,5)P2production impair several intracellular trafficking pathways, both constitutive and regulated, that emanate from or traverse the early endosomes (1013). In line with the requirement for PtdIns(3,5)P2in maintaining proper balance between membrane removal (fission) and membrane insertion (fusion), disrupted function of PIKfyve, the sole enzyme for PtdIns(3,5)P2synthesis, is phenotypically manifested by endosome vesicle swelling and endomembrane vacuolation seen in a number of mammalian cell types (7). As unraveled recently, PIKfyve is engaged in an unusual physical interaction with the phosphatase Sac3 that turns over PtdIns(3,5)P2, forming a common endogenous complex (the PAS core complex) organized by the PIKfyve activator ArPIKfyve (9,14). The ternary association, scaffolded by ArPIKfyve homomeric interactions, activates the PIKfyve kinase as evidenced by recent data for reduced PIKfyve activity upon disintegration of the PAS core (14). However, whereas the assembly of the three proteins in the PAS core is critical for PIKfyve activation and regulated PtdIns(3,5)P2production, whether the same complex is a functional platform for Sac3 enzymatic activity is currently unknown. PIKfyve, ArPIKfyve, and Sac3 are large, evolutionarily conserved proteins encoded by single-copy genes from yeast to humans. They all incorporate a range of functional domains (7). In the case of PIKfyve, there is an N-terminal-positioned FYVE finger domain that targets the protein to PtdIns(3)P-enriched endosome membranes (15). Next is the DEP domain, still with an uncharacterized function. The middle part of the molecule (residues 5601438) is occupied by two domains: Cpn60_TCP1, with sequence similarity to molecular chaperonins, and a CHK homology region, with conserved Cys, His, and Lys residues uniquely displayed by the PIKfyve orthologs (7). The Oxtriphylline region of conserved Lys is homologous to spectrin repeats. At the C terminus is the catalytic domain, responsible for the three PIKfyve kinase activities,i.e.synthesis of PtdIns(3,5)P2, PtdIns(5)P, and phosphoproteins, including phospho-PIKfyve (16,17). The aberrant endomembrane vacuolar phenotype has been first observed Oxtriphylline upon ectopic expression of kinase-deficient PIKfyve with a point mutation in the predicted ATP binding Lys1831of the catalytic domain (18). Similar defects have been confirmed thereafter by small interfering RNA-mediated silencing and pharmacological inhibition of PIKfyve in different mammalian cell types (13,19). All these maneuvers, however, although preserving the proper intracellular localization of the enzyme (15), affect all three PIKfyve kinase activities. That the aberrant vacuolar phenotype is due to abrogated PtdIns(3,5)P2synthesis is evidenced by its appearance in cells expressing PtdIns(3,5)P2-deficient, but not PtdIns(5)P-deficient, PIKfyve point mutants and its subsequent reversal upon exogenous delivery of PtdIns(3,5)P2(17). Importantly, aberrant endomembrane vacuoles are no longer seen if PtdIns(3,5)P2-deficient PIKfyveK1831Eis mislocalized by disruption of its FYVE finger (18). Clearly, these data corroborate the conclusion that if properly localized PIKfyve mutants fail to produce PtdIns(3,5)P2, they can then trigger dominant-negative changes in mammalian cells, phenotypically manifested by endomembrane vacuoles. One puzzling observation awaiting clarification is the apparent inability of a Cpn60_TCP1-deletion PIKfyve mutant to induce endomembrane vacuoles despite its proper intracellular localization and lack ofin vitrolipid kinase activity (18). Considering the partner Sac3 phosphatase collaborating in parallel with PIKfyve in triggering the endomembrane defects by reducing localized PtdIns(3,5)P2levels, here we examined the interacting.